当前位置: X-MOL 学术J. Extracell. Vesicles › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Comprehensive palmitoyl-proteomic analysis identifies distinct protein signatures for large and small cancer-derived extracellular vesicles.
Journal of Extracellular Vesicles ( IF 16.0 ) Pub Date : 2020-06-10 , DOI: 10.1080/20013078.2020.1764192
Javier Mariscal 1 , Tatyana Vagner 1 , Minhyung Kim 1 , Bo Zhou 1, 2, 3 , Andrew Chin 1 , Mandana Zandian 1 , Michael R Freeman 1, 2, 3, 4 , Sungyong You 1, 3 , Andries Zijlstra 5 , Wei Yang 1, 2, 3, 4 , Dolores Di Vizio 1, 2, 3, 4, 6
Affiliation  

ABSTRACT

Extracellular vesicles (EVs) are membrane-enclosed particles that play an important role in cancer progression and have emerged as a promising source of circulating biomarkers. Protein S-acylation, frequently called palmitoylation, has been proposed as a post-translational mechanism that modulates the dynamics of EV biogenesis and protein cargo sorting. However, technical challenges have limited large-scale profiling of the whole palmitoyl-proteins of EVs. We successfully employed a novel approach that combines low-background acyl-biotinyl exchange (LB-ABE) with label-free proteomics to analyse the palmitoyl-proteome of large EVs (L-EVs) and small EVs (S-EVs) from prostate cancer cells. Here we report the first palmitoyl-protein signature of EVs, and demonstrate that L- and S-EVs harbour proteins associated with distinct biological processes and subcellular origin. We identified STEAP1, STEAP2, and ABCC4 as prostate cancer-specific palmitoyl-proteins abundant in both EV populations. Importantly, localization of the above proteins in EVs was reduced upon inhibition of palmitoylation in the producing cells. Our results suggest that this post-translational modification may play a role in the sorting of the EV-bound secretome and possibly enable selective detection of disease biomarkers.



中文翻译:

全面的棕榈酰蛋白质组学分析可识别大型和小型癌症来源的细胞外囊泡的不同蛋白质特征。

摘要

细胞外囊泡(EV)是膜包裹的颗粒,在癌症进展中发挥重要作用,并已成为循环生物标志物的有前途的来源。蛋白质S-酰化,通常称为棕榈酰化,已被提议作为一种翻译后机制,调节 EV 生物发生和蛋白质货物分选的动态。然而,技术挑战限制了电动汽车的整个棕榈酰蛋白的大规模分析。我们成功地采用了一种将低背景酰基生物素交换 (LB-ABE) 与无标记蛋白质组学相结合的新方法来分析前列腺癌的大 EV (L-EV) 和小 EV (S-EV) 的棕榈酰蛋白质组细胞。在这里,我们报告了 EV 的第一个棕榈酰蛋白特征,并证明 L-和 S-EV 含有与不同生物过程和亚细胞起源相关的蛋白质。我们将 STEAP1、STEAP2 和 ABCC4 鉴定为前列腺癌特异性棕榈酰蛋白,在两个 EV 群体中含量丰富。重要的是,在生产细胞中抑制棕榈酰化后,上述蛋白质在 EV 中的定位就会减少。我们的结果表明,这种翻译后修饰可能在 EV 结合分泌蛋白组的分选中发挥作用,并可能实现疾病生物标志物的选择性检测。

更新日期:2020-06-10
down
wechat
bug